cropped-Ativo-9.png

Elder Mello

CSO

Experienced professionals you can Believe Depend Rely

+ 0
Years of Experience

Elder Mello, a seasoned professional in the Pharmaceutical Industry, embarked on his career journey in 1983 as a Sales Representative at Merck S/A (Dexacitoneurin). Through invitations from various companies, he progressed through the industry, working with Searle Pharmaceutical (Cytotec), Degussa-Labofarma, and eventually attaining the role of Account Manager (Key Account Manager) at Kabi-Pharmacia-Sanofi Aventis, Rhodia Pharmaceutical (Taxotere), and Bristol Myers Squibb.

In the Oncology segment, Elder Mello showcased his expertise, achieving Sales Champion in 2001, for the launch of Taxotere (Docetaxel) and, later in 2002, with Taxol (Paclitacel) at BMS.

In 2003, he resigned from Bristol Myers Squibb to dedicate himself to industry consulting. This marked the transition from consulting to entrepreneurship, where he played a pivotal role as a founding partner in successful ventures such as CION – Integrated Center of Oncology in Porto Alegre, Neo Clínica Oncologia in Curitiba – Paraná, and Mem Holdings in Curitiba – Paraná.

In 2019, Elder Mello founded the MVE Business Hub in Sacramento, CA, United States. Through this venture, he brought knowledge about the Medicinal Cannabis segment to Brazil. As the headquarter of MVE Business Hub, based in Curitiba – Paraná and a partner of TM Pharmaceutical S/A in Miami-Florida, he successfully launched two cannabinoid products in the Brazilian market in 2021.

Over 3,000 patients have been treated in the past two years with remarkable results in pathologies such as Alzheimer’s, Autism, Anxiety, Depression, Panic Syndrome, Sleep Disorders, and others.

As associates of Casa Hunter (13 million patients), the largest organization dedicated to the treatment of Rare Diseases in Brazil, Elder Mello and TM Pharmaceutical are actively prospecting business opportunities with a focus on assisting patients, including those with low purchasing power, through Casa dos Raros based in Porto Alegre. In 2024, they will commence actions in the Cannabinoid Unit to aid these patients.

Elder Mello believes that exalted wisdom guides people in the paths to be followed to improve the lives of patients in Brazil and potentially in other countries in the future.

A group company of

© 2024 MediGlobo

Created By Morro Alto – Creative Office

Shopping Basket

HOSPITALS AND CLINICS (FINAL CLIENT)

MARKET NEEDS

HOW MEDIGLOBO WILL ANSWER TO THAT





Bad Communication with Producer brands
Ambassadors Board

MediGlobo is inviting a select group of cardiologists to become Translumina Ambassadors. Each State is going to have a nominated Ambassador, recognized by its influence and experience on the cardiology field. This ambassador will have two main objectives. The first one is to provide information and technical support to the distributors in the state and be the representative of the brand on the main cadiology events. The ambassadors will be responsable for assisting in the first uses of Translumina products and assure its correct uses, providing feedback on market opening and avoiding implantation problems.
The second goal is to provide information to MediGlobo about the market needs, new technologic features and new products on the market. This way MediGlobo can keep in touch with transluminal and update the commercial strategies based on the market changes.

DISTRIBUTORS

MARKET NEEDS

HOW MEDIGLOBO WILL ANSWER TO THAT



Distributors have very high TARGET GOAL and MINIMUM PERIODIC PURCHASE AGREEMENTS that are not consistent with market performance.

Fair Goals

Through the close relationship with the distributor and the analysis of the market indicators MediGlobo intend to have its own store warehouse facility and plan with the distributors fair target goals, providing marketing materials and benefits to boost sales.



Brands doesn’t have a close relationship with the distributors

Communication

Our main strategy is to have a close relationship with the distributors through exclusive channels. The MediGlobo app is going to be used by the distributor as an open channel to the communication with MediGlobo and also provide features to be used on Marketing and approach with the consumer with complete info about the products.

Complete Data